Clear evidence. Transparent sources. Practical guidance. Our evidence policyContact
Food Health Lab
Home › Supplements › Brain & cognition › Lion’s mane

Lion’s mane (Hericium erinaceus)

A great story, a plausible mechanism, and — so far — a handful of tiny human trials. Here is the honest gap between what the marketing claims and what has actually been shown.

Reviewed by Bodil Isaksson, Licensed Biomedical Scientist (Sweden)Last reviewed July 2026Supplement guide

SupplementsBrain & cognitionMostly hype

Lion’s mane is the darling of the nootropic corner of the internet, and you can see why: it is a real, edible mushroom, it contains compounds that boost nerve growth factor in a dish, and the before-and-after anecdotes are enthusiastic. What is missing is the part that would make it more than a good hypothesis — large, replicated human trials. The lab and animal data are genuinely interesting. The human data are thin. Both things are true, and the marketing only tells you the first.

Key takeaways

  • Mechanism is real in the lab: erinacines and hericenones can raise nerve growth factor in cell and animal models.
  • The best-known human trial was 30 older adults with mild cognitive impairment; scores improved on treatment and slid back after stopping.1
  • Other small studies point mostly at mood and sleep, not raw cognition, and samples are tiny.2
  • It is safe and food-derived, so a trial is low-risk — just calibrate expectations to “maybe a little,” not the marketing.

Why the hype exists

Lion’s mane contains two families of compounds — hericenones in the fruiting body and erinacines in the mycelium — that stimulate nerve growth factor (NGF), a protein involved in the survival and repair of neurons. In cell cultures and rodents that translates into effects on nerve regeneration and memory tasks, which is legitimately exciting biology. The leap the marketing makes is treating “raises NGF in a mouse” as if it were “makes you think faster,” and those are very different claims separated by the evidence that has not been done yet.

The human evidence, honestly

The most cited human study randomized just 30 older Japanese adults with mild cognitive impairment to lion’s mane or placebo for 16 weeks. The treatment group improved on a cognitive scale — but scores returned toward baseline four weeks after they stopped, suggesting any effect was temporary and support-dependent.1 Beyond that, the human literature is a scatter of small trials pointing more at reduced anxiety and better sleep than at memory or focus,2 plus a few acute studies with mixed results. No large trial, no long follow-up, no dementia-prevention data. This is early-stage evidence, and it should be described that way.

Dose, form and what to look for

Studied doses cluster around 1–3 g/day of dried mushroom or extract, split across the day. A real practical issue is product quality: many supplements are grown on grain and are heavy on mycelium and starchy substrate rather than the fruiting body, and the two contain different active compounds. If you try it, look for a product that states it is fruiting-body (or a well-characterised erinacine-rich mycelial extract) with the part of the mushroom specified — and treat a vague “mushroom blend” with suspicion.

Should you bother?

Honestly, it depends on your tolerance for paying to run your own experiment. It is a food, it is safe (rare allergy/skin reactions aside), and the downside is mostly your money. So if you are curious, a two- to three-month trial of a reputable fruiting-body product is reasonable — just track something concrete and be ready to conclude “nothing changed,” because for most people that is the likely result. What it is not is a proven cognitive enhancer or a treatment for any neurological condition, and anyone selling it as either has gotten ahead of the science.

Bottom line: promising mechanism, genuinely thin human evidence. Low-risk to trial at 1–3 g/day of a fruiting-body product for a few months, but keep expectations small — the hype far outruns the data.

References

Adult research summary for education, not a prescription. These are food supplements, not treatments for disease.

  1. Mori K, Inatomi S, Ouchi K, Azumi Y, Tuchida T. Improving effects of the mushroom Yamabushitake (Hericium erinaceus) on mild cognitive impairment: a double-blind placebo-controlled clinical trial. Phytother Res 2009;23(3):367–372. pubmed.ncbi.nlm.nih.gov
  2. Vigna L, Morelli F, Agnelli GM, et al. Hericium erinaceus improves mood and sleep disorders in patients affected by overweight or obesity. Evid Based Complement Alternat Med 2019;2019:7861297. pubmed.ncbi.nlm.nih.gov

This article summarises nutrition science for education. It is not a substitute for individual medical advice; consult a professional before starting a supplement, in pregnancy, or alongside medication.